XML 54 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quarterly Financial Summary (Unaudited)
 12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Summary (Unaudited)
Quarterly Financial Summary (Unaudited):
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
(In thousands, except per share amounts)
2015
 
 
 
 
 
 
 
Net sales
$
884,404

 
$
931,485

 
$
905,093

 
$
930,353

Gross profit
$
258,466

 
$
300,566

 
$
312,210

 
$
325,630

Restructuring and other, net(a)
$
—

 
$
—

 
$
(6,804
)
 
$
—

Acquisition and integration related costs(b)
$
59,523

 
$
24,166

 
$
42,798

 
$
19,609

Net income attributable to Albemarle Corporation(c)
$
43,115

 
$
52,147

 
$
65,392

 
$
174,252

Basic earnings per share(c)
$
0.40

 
$
0.46

 
$
0.58

 
$
1.55

Shares used to compute basic earnings per share
108,130

 
112,189

 
112,202

 
112,207

Diluted earnings per share(c)
$
0.40

 
$
0.46

 
$
0.58

 
$
1.55

Shares used to compute diluted earnings per share
108,464

 
112,607

 
112,544

 
112,608

 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
(In thousands, except per share amounts)
2014
 
 
 
 
 
 
 
Net sales
$
599,843

 
$
604,721

 
$
642,418

 
$
598,566

Gross profit
$
195,599

 
$
207,363

 
$
205,446

 
$
162,440

Restructuring and other, net(a)
$
17,000

 
$
3,332

 
$
293

 
$
5,322

Acquisition and integration related costs(b)
$
—

 
$
4,843

 
$
10,261

 
$
15,054

Net income (loss) from continuing operations
$
66,004

 
$
89,404

 
$
88,019

 
$
(12,990
)
Loss from discontinued operations (net of tax)(d)
(1,769
)
 
(60,025
)
 
(6,679
)
 
(1,058
)
Net income attributable to noncontrolling interests
(7,652
)
 
(6,932
)
 
(8,546
)
 
(4,460
)
Net income (loss) attributable to Albemarle Corporation
$
56,583

 
$
22,447

 
$
72,794

 
$
(18,508
)
Basic earnings (loss) per share:
 
 
 
 
 
 
 
Continuing operations
$
0.73

 
$
1.05

 
$
1.02

 
$
(0.22
)
Discontinued operations
(0.02
)
 
(0.76
)
 
(0.09
)
 
(0.02
)
 
$
0.71

 
$
0.29

 
$
0.93

 
$
(0.24
)
 
 
 
 
 
 
 
 
Shares used to compute basic earnings per share
79,735

 
78,662

 
78,244

 
78,144

Diluted earnings (loss) per share:
 
 
 
 
 
 
 
Continuing operations
$
0.73

 
$
1.04

 
$
1.01

 
$
(0.22
)
Discontinued operations
(0.02
)
 
(0.76
)
 
(0.08
)
 
(0.02
)
 
$
0.71

 
$
0.28

 
$
0.93

 
$
(0.24
)
 
 
 
 
 
 
 
 
Shares used to compute diluted earnings per share
80,112

 
79,091

 
78,659

 
78,545

(a)
See Note 21, “Restructuring and Other.”
(b)
See Note 2, “Acquisitions.”
(c)
The fourth quarter of 2015 includes an income tax benefit of $44.6 million primarily related to the release of certain tax reserves associated with lapses in statutes of limitations and audit closures.
(d)
Included in Loss from discontinued operations (net of tax) for the year ended December 31, 2014 is ($65.7) million related to the loss on the sale of our antioxidant, ibuprofen and propofol businesses and assets, the majority of which was recorded in the second quarter. See Note 3, “Divestitures.”

As discussed in Note 1, “Summary of Significant Accounting Policies,” actuarial gains and losses related to our defined benefit pension and OPEB plan obligations are recognized annually in our consolidated statements of income in the fourth quarter and whenever a plan is determined to qualify for a remeasurement during a fiscal year. During the year ended December 31, 2015, actuarial gains were recognized as follows: fourth quarter—$38.9 million ($27.8 million after income taxes) as a result of the annual remeasurement process. During the year ended December 31, 2014, actuarial losses were recognized as follows: first quarter—$15.4 million ($9.8 million after income taxes) as a result of the remeasurement of the assets and obligations of (i) one of our U.S. defined benefit plan which covers non-represented employees, and (ii) our SERP, in connection with a realignment of of our operating segments effective January 1, 2014 and related workforce reduction plan; third quarter—$2.8 million ($1.8 million after income taxes) as a result of the remeasurement of the assets and obligations of one of our U.S. defined benefit plans for represented employees which was part of the businesses and assets we divested on September 1, 2014; fourth quarter—$112.6 million ($71.8 million after income taxes) as a result of the annual remeasurement process.